While all these studies (on Neuroplastin, Synaptophysin and GAP-43) were done on postmortem human tissues, the inconsistency between the results of these studies and ours may be due to the differences in mechanisms underlying the induction of AD-like symptoms by STZ. The gene discussed is SYP; the disease is Alzheimer disease.